Menu
Not yet recruiting NCT07120243

Clinical Effectiveness of Bioactive Silica Based With Calcium Toothpaste

No phase Interventional Caries; Initial Caries Active

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Toothpaste Product, Varnishes, Fluoride.
Who it may be relevant to
Registry conditions: Caries; Initial, Caries Active. Basic parameters: 22 years — 55 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical Effectiveness of Bioactive Silica Based With Calcium Toothpaste, Sodium Fluoride Varnish in Management of White Spot Lesions (A 6m Randomized Clinical Trial).

Overview

This study will be conducted to Clinically evaluate Bioactive Silica Based with calcium booster (Refix technology) toothpaste and Sodium Fluoride varnish versus conventional fluoride toothpastes in management of white spot lesions of adult patients over 6m follow up and evaluating patient perception regarding the treatment provided.

Interventions

  • Procedure Toothpaste Product
    Administration ofa toothpaste
  • Procedure Varnishes, Fluoride
    The tooth will be dried, and cotton roll isolated. According to manufacturer instructions, thin coat of the varnish will be applied on the teeth for 10 - 20 s using a microbrush in a horizontal sweeping motion , then drying with air will be done.

Primary outcome measures

  • Degree of Remineralization efficacy by Diagnodent [Time frame: change from the baseline, 1month, 3 months , 6 months after treatment]
Secondary outcome measures (2)
  • Carie Progression according to International Caries Detection and Assessment System (ICDAS) scale: [Time frame: change from the baseline, 1month, 3 months , 6 months after treatment]
  • Patient-reported outcome measures (PROMs): Patients perception of the treatment [Time frame: change from the baseline, 1month, 3 months , 6 months after treatment]

Eligibility criteria

Inclusion criteria

  • Patient with non cavitated carious WSL in at least one upper or lower tooth.
  • Teeth with active non cavitated white spot carious lesions on the cervical one third of the facial or lingual surfaces.

Teeth with initial carious lesions with score 1 or 2 according to The International Caries Detection and Assessment System (ICDAS).

  • Teeth with Diagnodent values between 14-20 that refers to early enamel caries.

Exclusion criteria

Patients with known allergies or adverse reactions to any ingredient of the tested materials.

  • Systematic disease and/ or physical disabilities that may affect participation.
  • Patients with white spots due to congenital reasons e.g. enamel hypomineralization.
  • Pregnant females with frequent vomiting attacks.
  • Smokers.
  • Excessive dietary or environmental exposure to acids.
  • Presence of surface cavitation or restorations .

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07120243 · CONS1R

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗